The HSCP office has written to IASLT to invite contributions to the consultation process on the National Clinical Guideline for the Appropriate Prescribing of Psychotropic Medication in People with Dementia. The National HSCP Office is preparing a submission in time for the closing date of 12th March, 2019.
The aim of the guideline is to make recommendations on the appropriate use of psychotropic medications (including antipsychotics, antidepressants, anticonvulsants, benzodiazepines, z type drugs, acetylcholinesterase inhibitors and memantine), for managing non-cognitive symptoms of dementia (also termed behavioural and psychological symptoms of dementia; BPSD). Although some psychotropic medications have shown modest efficacy in the treatment of some BPSD, in many instances their use is not evidence based, and they are linked to significant adverse events, including a risk of death. The National Clinical Effectiveness Committee (NCEC) prioritised this guideline in October 2018. The guideline is relevant to all people with dementia and in any setting (living in the community or in residential settings, including during episodes of admission to hospital).
Notice given to IASLT was very short therefore we ask that if you are in a position to contribute please correspond directly with the HSCP consultation email@example.com and copy firstname.lastname@example.org in your response. The consultation form and the guideline can be found here
-Consultation form (word doc).
Please note that the deadline for submission is Tuesday, 12th March at 12 midday.